435 related articles for article (PubMed ID: 23016581)
1. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
3. Oxidized antithrombin is a dual inhibitor of coagulation and angiogenesis: Importance of low heparin affinity.
Azhar A; Khan MS; Swaminathan A; Naseem A; Chatterjee S; Jairajpuri MA
Int J Biol Macromol; 2016 Jan; 82():541-50. PubMed ID: 26554332
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic antithrombin.
O'Reilly MS
Semin Thromb Hemost; 2007 Oct; 33(7):660-6. PubMed ID: 18000792
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.
Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L
Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058
[TBL] [Abstract][Full Text] [Related]
6. The heparin-binding site of antithrombin is crucial for antiangiogenic activity.
Zhang W; Swanson R; Izaguirre G; Xiong Y; Lau LF; Olson ST
Blood; 2005 Sep; 106(5):1621-8. PubMed ID: 15905187
[TBL] [Abstract][Full Text] [Related]
7. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells.
Zhang W; Chuang YJ; Jin T; Swanson R; Xiong Y; Leung L; Olson ST
Cancer Res; 2006 May; 66(10):5047-55. PubMed ID: 16707426
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.
Schedin-Weiss S; Richard B; Hjelm R; Olson ST
Biochemistry; 2008 Dec; 47(51):13610-9. PubMed ID: 19035835
[TBL] [Abstract][Full Text] [Related]
10. A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity.
Larsson H; Akerud P; Nordling K; Raub-Segall E; Claesson-Welsh L; Björk I
J Biol Chem; 2001 Apr; 276(15):11996-2002. PubMed ID: 11278631
[TBL] [Abstract][Full Text] [Related]
11. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.
Olson ST; Richard B; Izaguirre G; Schedin-Weiss S; Gettins PG
Biochimie; 2010 Nov; 92(11):1587-96. PubMed ID: 20685328
[TBL] [Abstract][Full Text] [Related]
13. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
[TBL] [Abstract][Full Text] [Related]
14. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
Mader JS; Smyth D; Marshall J; Hoskin DW
Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells.
Zhang W; Chuang YJ; Swanson R; Li J; Seo K; Leung L; Lau LF; Olson ST
Blood; 2004 Feb; 103(4):1185-91. PubMed ID: 14563633
[TBL] [Abstract][Full Text] [Related]
16. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
17. Structure of beta-antithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity.
McCoy AJ; Pei XY; Skinner R; Abrahams JP; Carrell RW
J Mol Biol; 2003 Feb; 326(3):823-33. PubMed ID: 12581643
[TBL] [Abstract][Full Text] [Related]
18. The role of Arg46 and Arg47 of antithrombin in heparin binding.
Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.
Richard B; Swanson R; Schedin-Weiss S; Ramirez B; Izaguirre G; Gettins PG; Olson ST
J Biol Chem; 2008 May; 283(21):14417-29. PubMed ID: 18375953
[TBL] [Abstract][Full Text] [Related]
20. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
